Pooled mean follow-up on-treatment for semaglutide users was 193 days (median 157 days, interquartile range (IQR) 85 to 331 days) and for sitagliptin users 195 days (median 160 days, IQR 95 to 322 days)
We have a large group of customers and that is not only in India, but we also cover other nations such as the U.S.A, Europe, South Africa, Korea and among other foreign countries
A separate submission for the diabetes indication is expected later
This multi-receptor action gives it broader effects on metabolism, potentially leading to more significant weight loss and glucose regulation compared to medications that only target GLP-1
MICC works best when paired with healthy eating, regular exercise, and follow-up visits with your healthcare provider